XML 11 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Preferred Stock
Series B Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning Balances at Dec. 31, 2022 $ 75,394 $ 5 $ 24 $ 495,818 $ (12,173) $ (409,381) $ 1,101
Beginning Balances (in shares) at Dec. 31, 2022   5,000 22,623        
Net loss (2,719)         (2,719)  
Unrealized income (loss) from foreign currency translation adjustments 120           120
Issuance of common stock in connection with vesting of stock awards (shares)     78        
Stock-based compensation 990     990      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (184)       (184)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (24)        
Ending Balances at Mar. 31, 2023 73,601 $ 5 $ 24 496,808 (12,357) (412,100) 1,221
Ending Balances (in shares) at Mar. 31, 2023   5,000 22,677        
Beginning Balances at Dec. 31, 2023 74,272 $ 5 $ 25 500,752 (12,969) (414,870) 1,329
Beginning Balances (in shares) at Dec. 31, 2023   5,000 23,247        
Net loss (4,558)         (4,558)  
Unrealized income (loss) from foreign currency translation adjustments (290)           (290)
Issuance of common stock in connection with vesting of stock awards (shares)     120        
Stock-based compensation 1,019     1,019      
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (277)       (277)    
Shares withheld in payment of taxes in connection with net share settlement of restricted stock units (shares)     (33)        
Ending Balances at Mar. 31, 2024 $ 70,166 $ 5 $ 25 $ 501,771 $ (13,246) $ (419,428) $ 1,039
Ending Balances (in shares) at Mar. 31, 2024   5,000 23,334